International Immunology Advance Access published online on August 23, 2004
International Immunology, doi:10.1093/intimm/dxh146
© 2004 by The Japanese Society for Immunology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Oral Microbiology, Asahi University School of Dentistry, 1851-1 Hozumi, Mizuho, Gifu 501-0296, Japan
* To whom correspondence should be addressed. E-mail: tomo527{at}dent.asahi-u.ac.jp.
Lipopolysaccharide (LPS) preparations from the periodontopathic bacterium Porphyromonas gingivalis (Pg-LPS) are thought to require Toll-like receptor (TLR)2 rather than TLR4, a receptor of Escherichia coli LPS (Ec-LPS), for activation of immune cells. However, we previously reported that P. gingivalis lipid A, an immunostimulatory principal component of LPS, and its synthetic counterpart activate cells through a TLR4-dependent pathway but not via TLR2. In the present study, a lipoprotein from Pg-LPS (Pg-LP) was shown to be a principal component for TLR2-mediated cell activation. Pg-LP was separated by hydrophobic interaction chromatography followed by preparative electrophoresis and identified by internal peptide sequencing as PG1828, a putative lipoprotein encoded in the P. gingivalis genome. The N-terminal structure was characterized as a triacylated lipopeptide using mass spectrometry. Pg-LP, as well as Ec-LPS, was potent in inducing IL-8 production in human gingival fibroblasts. From our results, we propose that Pg-LP is a powerful inflammatory factor of P. gingivalis.
Accepted July 15, 2004
Article
Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis
Abstract 
B activation; periodontal disease; Toll-like receptor.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Diya Zhang, Lili Chen, Shenglai Li, Zhiyuan Gu, and Jie Yan Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1{beta}, TNF-{alpha} and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS Innate Immunity, April 1, 2008; 14(2): 99 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Bastian, T. Braun, H. Bruns, M. Rollinghoff, and S. Stenger Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans J. Immunol., March 1, 2008; 180(5): 3436 - 3446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Asai, Y. Makimura, A. Kawabata, and T. Ogawa Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation J. Immunol., December 1, 2007; 179(11): 7674 - 7683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hashimoto, M. Furuyashiki, R. Kaseya, Y. Fukada, M. Akimaru, K. Aoyama, T. Okuno, T. Tamura, T. Kirikae, F. Kirikae, et al. Evidence of Immunostimulating Lipoprotein Existing in the Natural Lipoteichoic Acid Fraction Infect. Immun., April 1, 2007; 75(4): 1926 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Asai, Y. Makimura, and T. Ogawa Toll-like receptor 2-mediated dendritic cell activation by a Porphyromonas gingivalis synthetic lipopeptide J. Med. Microbiol., April 1, 2007; 56(4): 459 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Erridge, C. M. Spickett, and D. J. Webb Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2 Cardiovasc Res, January 1, 2007; 73(1): 181 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hashimoto, K. Tawaratsumida, H. Kariya, A. Kiyohara, Y. Suda, F. Krikae, T. Kirikae, and F. Gotz Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus. J. Immunol., September 1, 2006; 177(5): 3162 - 3169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hashimoto, K. Tawaratsumida, H. Kariya, K. Aoyama, T. Tamura, and Y. Suda Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components Int. Immunol., February 1, 2006; 18(2): 355 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Nahori, E. Fournie-Amazouz, N. S. Que-Gewirth, V. Balloy, M. Chignard, C. R. H. Raetz, I. Saint Girons, and C. Werts Differential TLR Recognition of Leptospiral Lipid A and Lipopolysaccharide in Murine and Human Cells J. Immunol., November 1, 2005; 175(9): 6022 - 6031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancuso, A. Midiri, C. Biondo, C. Beninati, M. Gambuzza, D. Macri, A. Bellantoni, A. Weintraub, T. Espevik, and G. Teti Bacteroides fragilis-Derived Lipopolysaccharide Produces Cell Activation and Lethal Toxicity via Toll-Like Receptor 4 Infect. Immun., September 1, 2005; 73(9): 5620 - 5627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sen, A. Q. Khan, Q. Chen, and C. M. Snapper In Vivo Humoral Immune Responses to Isolated Pneumococcal Polysaccharides Are Dependent on the Presence of Associated TLR Ligands J. Immunol., September 1, 2005; 175(5): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Asai, M. Hashimoto, H. M. Fletcher, K. Miyake, S. Akira, and T. Ogawa Lipopolysaccharide Preparation Extracted from Porphyromonas gingivalis Lipoprotein-Deficient Mutant Shows a Marked Decrease in Toll-Like Receptor 2-Mediated Signaling Infect. Immun., April 1, 2005; 73(4): 2157 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takeda and S. Akira Toll-like receptors in innate immunity Int. Immunol., January 1, 2005; 17(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|